110 related articles for article (PubMed ID: 9809982)
1. Transforming growth factor beta type I receptor kinase mutant associated with metastatic breast cancer.
Chen T; Carter D; Garrigue-Antar L; Reiss M
Cancer Res; 1998 Nov; 58(21):4805-10. PubMed ID: 9809982
[TBL] [Abstract][Full Text] [Related]
2. Decreased expression of TGF-beta cell surface receptors during progression of human oral squamous cell carcinoma.
Paterson IC; Matthews JB; Huntley S; Robinson CM; Fahey M; Parkinson EK; Prime SS
J Pathol; 2001 Apr; 193(4):458-67. PubMed ID: 11276004
[TBL] [Abstract][Full Text] [Related]
3. Deletion of one adenine base within the polyadenine tract of transforming growth factor-beta receptor type II in human MDA-MB-231 breast cancer cell line.
Park B; Jang JS; Park K
Int J Oncol; 2000 Sep; 17(3):473-8. PubMed ID: 10938386
[TBL] [Abstract][Full Text] [Related]
4. The S387Y mutations of the transforming growth factor-beta receptor type I gene is uncommon in metastases of breast cancer and other common types of adenocarcinoma.
Anbazhagan R; Bornman DM; Johnston JC; Westra WH; Gabrielson E
Cancer Res; 1999 Jul; 59(14):3363-4. PubMed ID: 10416594
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the functional binding sites for TGF-beta on the type II receptor leads to suppression of TGF-beta signaling.
Shimanuki T; Hara T; Furuya T; Imamura T; Miyazono K
Oncogene; 2007 May; 26(23):3311-20. PubMed ID: 17146441
[TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta receptor type I gene is frequently mutated in ovarian carcinomas.
Chen T; Triplett J; Dehner B; Hurst B; Colligan B; Pemberton J; Graff JR; Carter JH
Cancer Res; 2001 Jun; 61(12):4679-82. PubMed ID: 11406536
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of transforming growth factor beta type II receptor mutants in human cancer.
De M; Yan W; de Jonge RR; Garrigue-Antar L; Vellucci VF; Reiss M
Cancer Res; 1998 May; 58(9):1986-92. PubMed ID: 9581843
[TBL] [Abstract][Full Text] [Related]
8. A transforming growth factor-beta receptor-interacting protein frequently mutated in human ovarian cancer.
Ding W; Tang Q; Espina V; Liotta LA; Mauger DT; Mulder KM
Cancer Res; 2005 Aug; 65(15):6526-33. PubMed ID: 16061631
[TBL] [Abstract][Full Text] [Related]
9. Two divergent signaling pathways for TGF-beta separated by a mutation of its type II receptor gene.
Lu SL; Kawabata M; Imamura T; Miyazono K; Yuasa Y
Biochem Biophys Res Commun; 1999 Jun; 259(2):385-90. PubMed ID: 10362519
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of the transforming growth factor beta receptor type II gene in human ovarian carcinoma.
Lynch MA; Nakashima R; Song H; DeGroff VL; Wang D; Enomoto T; Weghorst CM
Cancer Res; 1998 Oct; 58(19):4227-32. PubMed ID: 9766642
[TBL] [Abstract][Full Text] [Related]
11. Inhibiting mutations in the transforming growth factor beta type 2 receptor in recurrent human breast cancer.
Lücke CD; Philpott A; Metcalfe JC; Thompson AM; Hughes-Davies L; Kemp PR; Hesketh R
Cancer Res; 2001 Jan; 61(2):482-5. PubMed ID: 11212236
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
13. Missense mutations of the transforming growth factor beta type II receptor in human head and neck squamous carcinoma cells.
Garrigue-Antar L; Muñoz-Antonia T; Antonia SJ; Gesmonde J; Vellucci VF; Reiss M
Cancer Res; 1995 Sep; 55(18):3982-7. PubMed ID: 7664267
[TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
[TBL] [Abstract][Full Text] [Related]
15. A mutation in the transforming growth factor beta type II receptor gene promoter associated with loss of gene expression.
Muñoz-Antonia T; Li X; Reiss M; Jackson R; Antonia S
Cancer Res; 1996 Nov; 56(21):4831-5. PubMed ID: 8895728
[TBL] [Abstract][Full Text] [Related]
16. Smad-binding defective mutant of transforming growth factor beta type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines.
Tian F; Byfield SD; Parks WT; Stuelten CH; Nemani D; Zhang YE; Roberts AB
Cancer Res; 2004 Jul; 64(13):4523-30. PubMed ID: 15231662
[TBL] [Abstract][Full Text] [Related]
17. Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas.
Goggins M; Shekher M; Turnacioglu K; Yeo CJ; Hruban RH; Kern SE
Cancer Res; 1998 Dec; 58(23):5329-32. PubMed ID: 9850059
[TBL] [Abstract][Full Text] [Related]
18. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
[TBL] [Abstract][Full Text] [Related]
19. Decreased expression of transforming growth factor beta receptor type I is associated with poor prognosis in bladder transitional cell carcinoma patients.
Tokunaga H; Lee DH; Kim IY; Wheeler TM; Lerner SP
Clin Cancer Res; 1999 Sep; 5(9):2520-5. PubMed ID: 10499628
[TBL] [Abstract][Full Text] [Related]
20. Expression of TGF-beta1 and its receptor genes (TbetaR I, TbetaR II, and TbetaR III-betaglycan) in peripheral blood leucocytes in patients with idiopathic pulmonary arterial hypertension and Eisenmenger's syndrome.
Jachec W; Foremny A; Domal-Kwiatkowska D; Smolik S; Tomasik A; Mazurek U; Wodniecki J
Int J Mol Med; 2008 Jan; 21(1):99-107. PubMed ID: 18097622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]